RecruitingAlzheimer Disease
UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy
Eligible age
50+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The primary objective of this study is to measure the concentration and the regional brain distribution of pathologic amyloid deposition using the PET tracer \[C-11\]PiB in participants in the UAB Alzheimer's Disease Center cohort. Assessment of interactions between race and vascular risk factors, brain amyloid levels measured with \[C-11\]PiB-PET, and cognitive status will be the primary outcome of this imaging study.
Sponsor: University of Alabama at Birmingham
You may qualify if…
- ✓ \- 1. Enrollment in the UAB-ADC study under a separate IRB-approved research protocol (IRB-300000169).
- ✓ 2\. Negative urine or serum B-hCG test within 2 days of \[C-11\]PiB administration in women of child bearing potential. Women who are post-menopausal with at least 1 year since last menses or documented surgical sterilization will not require pregnancy testing.
You may not qualify if…
- ✕ 1. Meets any exclusion criteria for the UAB-ADC study (IRB-300000169).
- ✕ 2. Inability or contraindication for undergoing MRI and/or PET imaging
- ✕ 3. Inability to participate in the imaging studies due to severity of dementia
Where it's recruiting
Alabama
Birmingham
Source: ClinicalTrials.gov · NCT03503331 · last updated 2025-12-11